Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Chemomab Therapeutics Reported On Its Poster Presentation At The American College Of Rheumatology Convergence 2023 Conference Highlighting Key Role Of Its CCL24 Target In The Pathogenesis Of Systemic Sclerosis

Author: Benzinga Newsdesk | November 16, 2023 08:19am

Posted In: CMMB